Related Experiment Video

Updated: Apr 18, 2026

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

8.6K

Analysis of spontaneous MEG activity in mild cognitive impairment and Alzheimer's disease using Jensen's divergence

Jesús Poza, Carlos Gómez, María García

    Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
    |January 9, 2015
    PubMed

    Insights

    Alzheimer's disease (AD) significantly alters brain dynamics, showing distinct neural irregularity patterns compared to mild cognitive impairment (MCI) and healthy individuals. These changes are region-specific, indicating progression markers.

    Area of Science:

    • Neuroscience
    • Biophysics
    • Medical imaging

    Background:

    • Mild cognitive impairment (MCI) and Alzheimer's disease (AD) represent a spectrum of neurodegenerative conditions.
    • Understanding alterations in brain dynamics is crucial for early diagnosis and tracking disease progression.
    • Magnetoencephalography (MEG) offers high temporal resolution for studying spontaneous neural activity.

    Purpose of the Study:

    • To analyze changes in brain dynamics associated with MCI and AD.
    • To quantify neural activity irregularity using Jensen's divergence.
    • To compare brain dynamics across AD patients, MCI subjects, and healthy controls.

    Main Methods:

    • Analysis of spontaneous magnetoencephalography (MEG) activity.
    • Inclusion of 36 AD patients, 18 MCI subjects, and 24 healthy controls.
    • Application of Jensen's divergence to measure neural dynamics irregularity.

    Main Results:

    • Significant differences in neural irregularity patterns were observed in AD patients compared to MCI subjects and healthy controls (p<0.05).
    • Subtle differences in neural dynamics were detected between MCI subjects and elderly controls.
    • Region-specific abnormalities in neural activity patterns were associated with AD progression.

    Conclusions:

    • Alzheimer's disease is characterized by distinct, region-specific alterations in brain dynamics.
    • Jensen's divergence can effectively detect changes in neural irregularity related to AD.
    • These findings highlight potential biomarkers for tracking AD progression and differentiating from MCI.

    More Related Videos

    Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases09:33

    Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

    Published on: July 28, 2013

    29.5K
    Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data14:27

    Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

    Published on: June 26, 2013

    16.5K

    Related Concept Videos

    Alzheimer Disease l: Introduction01:29

    Alzheimer Disease l: Introduction

    Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
    2
    Alzheimer's Disease: Overview01:26

    Alzheimer's Disease: Overview

    Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
    The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
    2.0K
    Alzheimer Disease ll: Pathophysiology01:23

    Alzheimer Disease ll: Pathophysiology

    Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
    1